Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001161697-24-000254)

Filing Details

Accession Number:: 0001161697-24-000254
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-06-05 17:00:50
Reporting Period:: 2024-06-04

Accepted Time:: 2024-06-05 17:00:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1369568	Catalyst Pharmaceuticals Inc.	CPRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1635393	J Richard Daly	355 Alhambra Circle Suite 801 Coral Gables FL 33134	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Acquisiton	2024-06-04	40,000	$4.01	252,147	No	4	M	Direct
Common Stock, Par Value $0.001 Per Share	Disposition	2024-06-04	17,323	$15.98	234,824	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Options to purchase common stock	Disposition	2024-06-04	40,000	$0.00	40,000	$4.01

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,731,012		2025-01-02	No	4	M	Direct

Footnotes

Shares were sold on the open market in order to fund the exercise price and tax withholding of the exercise of the stock option.
Derivative securities vested in three annual tranches beginning on January 2, 2019.